Irbesartan versus placebo in combination with standard cardiovascular protection ACE-I [ACE inhibitor] therapy with ramipril for the treatment of albuminuria in hypertensive subjects at elevated cardiovascular risk.
Latest Information Update: 03 Aug 2021
At a glance
- Drugs Irbesartan (Primary) ; Ramipril (Primary)
- Indications Hypertension; Proteinuria
- Focus Therapeutic Use
- Acronyms IMPROVE
- Sponsors Bristol-Myers Squibb
- 12 Jul 2007 New trial record.